InsidersTradesSigma
Browse the complete record of transactions filed by Ahmad Fuad, Chief Financial Officer. Director active across 1 companies, notably Vaxart, Inc.. In total, 1 reports have been recorded. Total volume traded: €15k. The latest transaction was filed on 22 June 2022 (Acquisition). Regulator: SEC (Form 4). The full history is free.
1 of 1 declaration
Fuad Ahmad serves as the Interim Chief Financial Officer at Vaxart, Inc. In this role, he is responsible for financial management and strategy. Vaxart, Inc. is a biopharmaceutical company specializing in vaccine development. Fuad leverages his expertise to optimize financial operations and support the company's growth.